Added Oct 29, 2026
Unlearn
PaidDigital twins of trial participants for clinical development
What is Unlearn?
Unlearn uses AI to build digital twins of clinical trial participants, which forecast an individual's outcomes. Pharma and biotech teams use them to design smaller studies, sharpen interim analyses and get more information out of the data they already collect.
The company frames clinical development as a chain of decisions and offers help at three points: before protocol lock, while the study is running, and after readout. Before lock, simulated twins of hypothetical participants let teams pressure-test eligibility, endpoints and sample size.
During a study, each enrolled participant gets a twin forecast that supports pre-specified interim analyses and mid-study design scenarios. Twins can also act as a comparator in randomized and single-arm studies. The site lists AI regulatory strategy expertise as part of the offer.
Features
- Participant digital twins
- Trial design simulation
- Interim analysis support
- Digital twin comparators
- Regulatory strategy expertise
Tags
Releases
+ Submit new release- Listed
Unlearn was added to the directory.
Organization
Unlearn
Listed by kitio.ai · unverified owner
Pricing
- Pricing model
- Paid
- Paid options from
- Not listed
Sponsored
Your AI tool here
A Featured launch puts your tool in this spot and on the home page for a week.
Top Unlearn alternatives
View allLegal, finance & HR
Agentic AI for life sciences regulatory and clinical documents
Legal, finance & HR
No-code deep learning for microscopy image analysis
Legal, finance & HR
Digital pathology platform with AI for labs and drug developers
Compare Unlearn
If you liked Unlearn
AI-powered digital pathology for labs and drug developers
PaidLegal, finance & HRMade in United StatesConversation intelligence for pharma teams that record HCP interactions
PaidLegal, finance & HRGenerative AI platform for designing new drug-like molecules
PaidLegal, finance & HR
Pros and cons
Pros
- Targets specific decisions across the trial lifecycle
- Can support smaller study designs
- Works for randomized and single-arm studies
Cons
- Enterprise service, no self-serve sign-up
- No published pricing
- Aimed only at clinical development teams
Prompts & results
No prompts yet. Add your own prompt and output to help others use this tool.
Share a prompt
Reviews
Q&A
What is Unlearn?
Unlearn uses AI to build digital twins of clinical trial participants, which forecast an individual's outcomes. Pharma and biotech teams use them to design smaller studies, sharpen interim analyses and get more information out of the data they already collect.
What is a digital twin in Unlearn's context?
It is an AI-generated forecast of one participant's clinical outcomes, used to plan, analyze and interpret a trial.
At what stage of a trial can Unlearn be used?
The site describes entry points before protocol finalization, during the study from first patient in through readout, and after readout when planning the next study.
How much does Unlearn cost?
Unlearn is paid.
Is there a free version of Unlearn?
No. Unlearn is a paid tool.
What are the main features of Unlearn?
Participant digital twins, Trial design simulation, Interim analysis support, Digital twin comparators, Regulatory strategy expertise.
Who makes Unlearn?
Unlearn is made by Unlearn.
What are the best alternatives to Unlearn?
Popular alternatives include Narrativa Navigator, Cradle, arivis Cloud.